Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraligamentary Dexamethasone, Diclofenac Sodium, and Chymotrypsin for Enhancing Articaine Anesthesia in Irreversible Pulpitis
NCT07506265Phase 4Completed
- Sponsor
- Fayoum University
- Start
- May 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, diclofenac, chymotrypsin in irreversible pulpitis, sponsored by Fayoum University. Started May 2025; status: completed.
02
Drugs
dexamethasonediclofenacchymotrypsin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07506265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07506265.